ADMA Biologics Inc (ADMA) News
Filter ADMA News Items
ADMA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ADMA News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest ADMA News From Around the Web
Below are the latest news stories about ADMA BIOLOGICS INC that investors may wish to consider to help them evaluate ADMA as an investment opportunity.
The Top Stock Funds of 2024The Magnificent Seven tech stocks and big AI players drove double-digit gains at many large-cap mutual funds. The top fund returned 51.8%. |
ADMA Stock Catapults 275.7% in a Year: How Should You Play the Stock?ADMA Biologics performance in the past twelve months has been phenomenal. While the prospects remain sound, the exceptional rally witnessed by the stock might limit any further gain. |
Is ADMA Biologics, Inc. (ADMA) the Best Growth Stock to Buy Now Under $25?We recently compiled a list of the 12 Best Growth Stocks Under $25 to Buy Now. In this article, we are going to take a look at where ADMA Biologics, Inc. (NASDAQ:ADMA) stands against the other growth stocks. AI is the Most Defining Theme of 2025, Says Expert Most experts agree that the AI wave is […] |
Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth KnowingAdma Biologics (ADMA) closed at $18.56 in the latest trading session, marking a +1.48% move from the prior day. |
SpringWorks Therapeutics Stock Gets A RS Rating LiftSpringWorks Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating |
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?According to the average brokerage recommendation (ABR), one should invest in Adma Biologics (ADMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock? |
High Growth Tech Stocks to Watch in January 2025The United States market has shown robust performance recently, with a 1.3% increase over the last week and a significant 24% rise over the past year, while earnings are anticipated to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for revenue expansion and innovation in line with these positive market trends. |
ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025RAMSEY, N.J. and BOCA RATON, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced that Company management will present at the 43rd Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 13-16, 2025. ADMA’s presentation will be on Monday, January 13, 2025, at 10:30 a.m. PT. |
Why Is ADMA Biologics, Inc. (ADMA) Among the Best Multibagger Stocks to Buy Right Now?We recently compiled a list of the 12 Best Multibagger Stocks to Buy Right Now. In this article, we are going to take a look at where ADMA Biologics, Inc. (NASDAQ:ADMA) stands against the other multibagger stocks. The US equities continued their upward movement in 2024 and fueled the S&P 500 to record highs. Much of this […] |
Are Medical Stocks Lagging Alvotech (ALVO) This Year?Here is how Alvotech (ALVO) and Adma Biologics (ADMA) have performed compared to their sector so far this year. |